Potent natural products and herbal medicines for treating liver fibrosis
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Liver fibrosis is a wound-healing response to chronic liver injury characterized by progressive inflammation and deposition of extracellular matrix components. The pathological condition of liver fibrosis involves secretion of extracellular matrix proteins and formation of scar tissue. The major regulators involved in hepatic fibrogenesis are the transforming growth factor (TGF)-β1/SMAD and toll-like receptor 4 (TLR4)-initiated myeloid differentiation primary response 88 gene (MyD88)/NF-ĸB cell signaling pathways. This article reviews natural products and herbal medicines that have demonstrated activity against liver fibrosis through different mechanisms of action, including anti-hepatitis B and C virus activity, anti-inflammation, inhibition of cytokine production and nuclear receptor activation, and free radical scavenging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Luedde, T., & Schwabe, R. F. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.213 · Cited by 1,345
Identification of a nuclear receptor that is activated by farnesol metabolites
Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., & Mangelsdorf, D. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.049 · Cited by 1,015
Mudaliar, S., Henry, R. R., Sanyal, A. J., Morrow, L., Marschall, H., Kipnes, M., Adorini, L., Sciacca, C. I., Clopton, P., Castelloe, E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.042 · Cited by 931 · cited 2×
“Patients with type 2 diabetes and non-alcoholic fatty liver disease showed significantly reduced markers of liver inflammation and fibrosis after administration of 25 mg obeticholic acid for 6 weeks in a phase II clinical trial in the US [112].”
BackgroundMechanisms of hepatic fibrogenesis
Lee, U. E., & Friedman, S. L. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.005 · Cited by 923
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805
Meng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711 · cited 1×
“Treatment of these kinds of cytokine inhibitors could contribute to inflammation accumulation in the fibrotic liver [68].”
BackgroundFree radicals and antioxidants – quo vadis?
Halliwell, B. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.12.002 · Cited by 706 · cited 1×
“Reactive oxygen species (ROS) are related to chronic liver damage and fibrogenesis [31].”
BackgroundA vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response
Ding, N., Yu, R. T., Subramaniam, N., Sherman, M. H., Wilson, C., Rao, R., Leblanc, M., Coulter, S., He, M., Scott, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.028 · Cited by 622 · cited 2×
“VDR ligands prevent liver fibrosis by deactivation of HSCs through downregulation of the TGF-β1/SMAD pathway [25].”
Background
Cited by
Research progress on the anti-hepatic fibrosis action and mechanism of natural products
Shan, L., Liu, Z., Ci, L., Shuai, C., Lv, X., & Li, J. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105765 · Cited by 111
Ayurvedic drug induced liver injury
Dalal, K. K., Holdbrook, T., & Peikin, S. R. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i31.1205 · Cited by 12
Hepatoprotective activity assessment of amino acids derivatives of picroside I and II
Dong, P., Gao, Z., Yin, X., Li, Z., & Han, H. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13786 · Cited by 5
Metadata
- Authors
- Chen, S.-R., Chen, X.-P., Lu, J.-J., Wang, Y., & Wang, Y.-T.
- Venue
- Chinese Medicine
- Published
- 2015-04-15
- Volume
- 10
- Issue
- 1
- Pages
- 7-7
- ISSN
- 1749-8546 (ISSN-L)
- OpenAlex
- W1994376610
- Cited by
- 64
- References
- 16
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potent natural products and herbal medicines for treating liver fibrosis. https://app.cochat.ai/papers/10.1186/s13020-015-0036-y
- The paper
- Chen, S.-R., Chen, X.-P., Lu, J.-J., Wang, Y., & Wang, Y.-T. (2015). Potent natural products and herbal medicines for treating liver fibrosis. Chinese Medicine. https://doi.org/10.1186/s13020-015-0036-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.